Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Neurol Clin. 2007 Aug;25(3):611-67, v.

    Genetics of Alzheimer's disease: a centennial review.

    Source

    Department of Neurology, Mayo Clinic Rochester, Rochester, MN 55905, USA. taner.nilufer@mayo.edu

    Abstract

    Alzheimer's disease (AD) genetics may be one of the most prolifically published areas in medicine and biology. Three early-onset AD genes with causative mutations (APP, PSEN1, PSEN2) and one late-onset AD susceptibility gene, apolipoprotein E (APOE), exist with ample biologic, genetic, and epidemiologic data. Evidence suggests a significant genetic component underlying AD that is not explained by the known genetic risk factors. This article summarizes the evidence for the genetic component in AD and the identification of the early-onset familial AD genes and APOE, and examines the current state of knowledge about additional AD susceptibility loci and alleles. The future directions for genetic research in AD as a common and complex condition are also discussed.

    PMID:
    17659183
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2735049
    Free PMC Article

    Images from this publication.See all images (1)Free text

    FIGURE 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk